NexGel, Inc. engages in the manufacture of aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company is headquartered in Langhorne, Pennsylvania and currently employs 19 full-time employees. The company went IPO on 2021-12-22. The company is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The firm operates through two segments: NexGel and CGN. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CGN segment comprises CG Converting and Packaging, LLC (CGN), a joint venture with C.G. Laboratories Inc. (CG Labs) used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Silly George.
Follow-Up Questions
Who is the CEO of Nexgel Inc?
Mr. Adam Levy is the President of Nexgel Inc, joining the firm since 2019.
What is the price performance of NXGL stock?
The current price of NXGL is $2.59, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Nexgel Inc?
Nexgel Inc belongs to Health Care industry and the sector is Health Care
What is Nexgel Inc market cap?
Nexgel Inc's current market cap is $20.9M
Is Nexgel Inc a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for Nexgel Inc, including 2 strong buy, 4 buy, 1 hold, 0 sell, and 2 strong sell
